Big Buttons

• FDA doubles down: Tirzepatide is off shortage

  ...but that doesn't mean the issue is completely settled. read more →

• A couple of state updates

  Good news from Alabama, but a problem in Massachusetts read more →

• Defending GLP-1 compounding

  The latest letters APC's been sending to oppose efforts to restrict compounding read more →

• Thumbs-up for FDA crackdown

  APC was thrilled when the FDA announced it was taking action against illegal online businesses claiming to sell “research-grade” compounds. read more →

• A PANS/PANDAS explainer

  For your patients: Information about a couple of underdiagnosed pediatric mental health conditions read more →

• What, a year?

  In the final board chair column of the year, here are our top 7 accomplishments in 2024. read more →

• “Simply not a rational approach to regulating an industry”

  This week APC offered its final (and pointed) suggestions to the California Board of Pharmacy on their proposed significant – and we would say unjustified – changes to their compounding regulations. read more →

• Get a cease and desist letter from Verrica?

  APC has heard reports from several pharmacies that have received them — here's what to know. read more →

More News

A new benefit for APC Pharmacy/Facility Members is discounted pricing on Love Lifesciences’ UniPen injector pen — it’s similar to ‘dial-a-dose’ injectors used by insulin pens and brand-name GLP-1 drugs, and it can be easier for some patients to use than a traditional needle and vial. 

This is the first product of its kind we’ve seen, and considering the number of injectable meds on the market, it could — dare we say it? — be a game-changer for patients who use injectable drugs. Love also says it can help increase adherence and make it easier to choose the correct dose.

(Not a PFM? Learn more about all the benefits at a4pc.org/pfm.)